GGrantIndex
Sort

166,118 grants matching stem cells

AISL: Innovations in Development: Community-Driven Projects That Adapt Technology for Environmental Learning in Nature Preserves

$1,195,642
Jennifer J Preece · University Of Maryland, College Park · · FY2015 · EDU

1/3: The Chicago Cancer Health Equity Collaborative (ChicagoCHEC)

$1,195,558
Melissa A. Simon · Northwestern University At Chicago · U54 · FY2023 · CA

Promoting T cell reconstitution after hematopoietic cell transplantation

$1,195,546
Jarrod Dudakov · Fred Hutchinson Cancer Center · R35 · FY2024 · HL

Promoting T cell reconstitution after hematopoietic cell transplantation

$1,195,546
Jarrod Dudakov · Fred Hutchinson Cancer Center · R35 · FY2025 · HL

Microenvironmental control of progenitors in organ dysfunction and repair

$1,195,425
Jay W Schneider · Ut Southwestern Medical Center · U01 · FY2012 · HL

Epigenetic strategies for the in vitro generation of replacement beta cells

$1,195,258
Maike Sander · University Of California, San Diego · U01 · FY2011 · DK

Underpinnings of corneal innervation: anatomical, molecular, and functional studies of corneal sensory afferents in physiologic and pathologic states

$1,195,210
Panteleimon Rompolas · University Of Pennsylvania · U01 · FY2022 · EY

Resource Section - Core 001

$1,195,194
Terry R Magnuson · Univ Of North Carolina Chapel Hill · U42 · FY2024 · OD

A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform

$1,195,189
Shawn Hingtgen · Univ Of North Carolina Chapel Hill · U01 · FY2021 · TR

Mutant Mouse Resource and Research Center at UC Davis

$1,195,115
Kc Kent Lloyd · University Of California At Davis · U42 · FY2020 · OD

GrowthDifferentiation Factors in Organogenesis

$1,194,902
Alan Perantoni · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Activation of Proto-Oncogenes by Chromosomal Translocation

$1,194,872
Peter D Aplan · Clinical Sciences · Z01 · FY2007 · CA

Treatment of Neural Injury with MSCs

$1,194,758
Henry Ford Health System · P01 · FY2003 · NS

Unravelling Mechanisms and Novel Therapeutic Targets for Peripheral Neuropathy and Neuropathic Pain

$1,194,750
Clifford J Woolf · Boston Children'S Hospital · R35 · FY2025 · NS

Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging

$1,194,665
Xianyu S Hou · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Nonmyeloablative allogeneic PBSC in globin disorders

$1,194,259
John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL

Customized stem cells for clinical application in blood disorders

$1,193,861
George Q Daley · Boston Children'S Hospital · R24 · FY2013 · DK

Regulation of the cell cycle by cyclin-dependent kinases

$1,193,664
Philipp Kaldis · Clinical Sciences · Z01 · FY2007 · CA

CIP Genomics Core

$1,193,382
Colm Ohuigin · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA

Administrative Core

$1,193,379
Lin Liu · Oklahoma State University Stillwater · P20 · FY2021 · GM

Enhancer-based Immune and Beta Cell Dysregulation Underlying T1D Risk

$1,193,316
Yousin Suh · Columbia University Health Sciences · R01 · FY2020 · DK

Oligodendroglial Interactions Group

$1,193,279
Tobias Merson · National Institute Of Mental Health · ZIA · FY2025 · MH

Effects of cornea epithelial barrier disruption on the cornea trigeminal neural circuit

$1,193,265
Stephen Carl Pflugfelder · Baylor College Of Medicine · U01 · FY2022 · EY

Phase II study: Mobilization of progenitor cells in peripheral arterial disease

$1,193,039
Arshed A Quyyumi · Emory University · RC2 · FY2010 · HL

Induced pluripotent stem cells in the understanding and treatment of heart diseas

$1,193,016
Joseph C Wu · Stanford University · U01 · FY2012 · HL